Impact of cancer on the prevalence, management, and outcome of patients with chronic thromboembolic pulmonary hypertension.
Junichi NakamuraIchizo TsujinoHideki ShimaToshitaka NakayaAyako SugimotoTakahiro SatoTaku WatanabeHiroshi OhiraMasaru SuzukiIsao YokotaSatoshi KonnoPublished in: Journal of thrombosis and thrombolysis (2023)
17% of our patients with CETPH were diagnosed with cancer, with breast and gastrointestinal tract cancers being the most common. Cancer comorbidity was associated with a poor prognosis and contributed to death in 46% of deceased patients. The impact of cancer on CTEPH should be further evaluated in the future.